RxDoctor Payments Data

Peter Christie, DO

Family Medicine · Media, PANPI 1205805413

Payments from drug & device makers

$927in general payments, 2019–2025

Across 51 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$271
  • Lilly USA, LLC$207
  • Novo Nordisk$88
  • Merck$63
  • Kowa Pharmaceuticals America, Inc.$63
  • Bayer$53
  • plus $181 from 6 others

What the payments were for

  • Food & beverage$89897%
  • Education$303%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$927 in reported general payments places this provider in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$85,651
Medicare patients
265
Services billed
686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide42$39,778
EliquisApixaban25$24,124
JanuviaSitagliptin Phosphate13$19,498
RybelsusSemaglutide14$18,148
Ezetimibe142$4,523
Atorvastatin Calcium282$3,139
SynthroidLevothyroxine Sodium39$2,993
Rosuvastatin Calcium244$2,948
Valsartan64$2,273
Albuterol Sulfate HfaAlbuterol Sulfate69$2,003
Metformin Hcl ErMetformin Hcl86$1,309
Amlodipine Besylate188$1,300
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$1,257
Metoprolol Succinate78$1,232
Losartan Potassium123$1,173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$207$39,77842 claims
PfizerEliquis$44$24,12425 claims
MerckJanuvia$63$19,49813 claims
Novo NordiskRybelsus$88$18,14814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Media

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →